Spain

Back to map

Showing 1-9 of 9 grants

Title Institution Researcher Program Duration Total Award Amount
Pioneering Immunotherapy: Fast-Tracking PS-Liposome Treatment for Type 1 Diabetes – Final Steps of the non-regulatory Package for a Breakthrough Therapy AHEAD THERAPEUTICS S.L Bruna Barneda Zahonero Cures 15-January-2026 to 14-January-2028 $361.900,13
Antigen-specific pMHCII nanoparticle immunoregulation to enable immunosuppression-free human SC-islet replacement in T1D Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Pere Santamaria Cures 01-October-2026 to 30-September-2029 $900.000,00
Transcriptional and epigenetic regulation of an anti-diabetogenic immunoregulatory cell pathway (PI: Pere Santamaria) Fundación la Caixa Mònica Zamora Villafaina Cures 31-December-2025 to 30-December-2028 $288.310,00
Targeting microexons and neural-related splicing programs to enhance in vitro beta cell maturation (PI: Manuel Irimia) Fundación la Caixa Mònica Zamora Villafaina Cures 01-December-2025 to 30-November-2028 $576.532,00
Telomere Dynamics and Cellular Senescence in Type 1 Diabetes Exploring Biomarkers and the Impact of LRH-1/NR5A2 Activation Fundacion Publica Andaluza Progreso y Salud (Cabimer) Benoit Gauthier Cures 01-September-2025 to 31-August-2027 $599.959,50
LRH-1/NR5A2-mediated immune coupled islet remodelling: A wound healing disease modifying therapeutic approach for type 1 diabetes mellitus Fundacion Publica Andaluza Progreso y Salud (Cabimer) Benoit Gauthier Cures 01-February-2023 to 31-July-2026 $744.939,00
Proof-of-concept of a sensor for the continuous monitoring of insulin fibrillation in an insulin pump (QUALinS) Universitat Politècnica de València Jorge Bondia Improving Lives 01-April-2026 to 31-March-2027 $199.333,56
Fully-automated insulin delivery system Adaptable to the use of adjunctIve THerapies in T1D (FAITH-T1D) Universitat Politècnica de València Jorge Bondia Improving Lives 01-May-2026 to 30-April-2028 $727.636,07
Examining the role of self-metabolites as autoantigens in Type 1 Diabetes (Self-MAIT1D) University of Santiago de Compostela Iria Gomez-Tourino Cures 01-March-2023 to 29-February-2028 $996.586,00